Skip to main content
Premium Trial:

Request an Annual Quote

Applied Precision Files for IPO

NEW YORK (GenomeWeb News) - Applied Precision filed for an initial public offering with the US Securities and Exchange Commission, the company said yesterday.
 
All shares of Applied Precision's common stock to be sold will be offered by the company. The number of shares to be offered and the price range have not yet been determined.
 
The underwriters of the offering will be CIBC World Markets. Cowen and Company and Canaccord Adams are co-managers, the company said.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.